Cargando…
Xyloketal B Attenuates Fatty Acid-Induced Lipid Accumulation via the SREBP-1c Pathway in NAFLD Models
The goal of this study was to examine the effects of xyloketal B on nonalcoholic fatty liver disease (NAFLD) and to explore the molecular mechanisms underlying its effects in both in vivo and in vitro models. We discovered an association between xyloketal B and the sterol regulatory element-binding...
Autores principales: | Zhang, Youying, Meng, Tian, Zuo, Ling, Bei, Yu, Zhang, Qihao, Su, Zhijian, Huang, Yadong, Pang, Jiyan, Xiang, Qi, Yang, Hongtu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484113/ https://www.ncbi.nlm.nih.gov/pubmed/28587208 http://dx.doi.org/10.3390/md15060163 |
Ejemplares similares
-
Xyloketal B, a marine compound, acts on a network of molecular proteins and regulates the activity and expression of rat cytochrome P450 3a: a bioinformatic and animal study
por: Su, Junhui, et al.
Publicado: (2014) -
Synthesis and Neuroprotective Action of Xyloketal Derivatives in Parkinson’s Disease Models
por: Li, Shichang, et al.
Publicado: (2013) -
Schisandra polysaccharide inhibits hepatic lipid accumulation by downregulating expression of SREBPs in NAFLD mice
por: Wang, Chun-Mei, et al.
Publicado: (2016) -
Design and Synthesis of Novel Xyloketal Derivatives and Their Protective Activities against H(2)O(2)-Induced HUVEC Injury
por: Liu, Shixin, et al.
Publicado: (2015) -
Xyloketal derivative C53N protects against mild traumatic brain injury in mice
por: Liang, Fengyin, et al.
Publicado: (2018)